Presurgical avelumab plus axitinib in an immunosenescent octogenarian with renal cell carcinoma invading the vena cava

Application of immune checkpoint inhibitors (ICIs) in elderly patients remains challenging due to the scarcity of safety and efficacy data. An 84 year-old female with a right renal cell carcinoma invading the vena cava received two cycles of avelumab plus axitinib. As the thrombus showed a marked re...

Descripción completa

Detalles Bibliográficos
Autores principales: Uematsu, Toshitaka, Kijima, Toshiki, Takada-Owada, Atsuko, Nishihara, Daisaku, Ishida, Kazuyuki, Kamai, Takao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9450157/
https://www.ncbi.nlm.nih.gov/pubmed/36092023
http://dx.doi.org/10.1016/j.eucr.2022.102205

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9450157/
https://www.ncbi.nlm.nih.gov/pubmed/36092023
http://dx.doi.org/10.1016/j.eucr.2022.102205

Ejemplares similares